Clinical Trials in Boston

Showing 3921-3940 of 17,836 trials

An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome

NCT05367960

This is a 4-year, open-label extension (OLE) study for subjects completing one of two double-blind clinical trials with BPN14770, Study BPN14770-CNS-301 (in adult males) and Study BPN14770-CNS-204 (in adolescent males).

Fragile X Syndrome

Tetra Discovery Partners314 participantsStarted Nov 2022

Irvine, California, United States • Orange, California, United States • Sacramento, California, United States +14 more locations

Active Not Recruiting< 1 mile

Identification of Predictors for Clinical Outcomes in Femoroacetabular Impingement Surgery

NCT04243447

The overarching goal of the study is to improve the surgical treatment outcomes of FAI, which is affecting an increasing number of military personnel and young active individuals in the general population. The proposed study will investigate critical patient, disease, and surgical treatment predictors of FAI surgery outcomes.

Femoracetabular Impingement

Washington University School of Medicine747 participantsStarted Feb 2020

Aurora, Colorado, United States • Iowa City, Iowa, United States • Boston, Massachusetts, United States +10 more locations

An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome

Identification of Predictors for Clinical Outcomes in Femoroacetabular Impingement Surgery

Find Trials by Condition in Boston

MB-105 in Patients With CD5 Positive T-cell Lymphoma

Expanded Access Protocol for Patients With Eosinophilic Esophagitis

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Comparing Surgery Versus Standard Physical Therapy in Treating People With a Meniscal Tear and Osteoarthritis

A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1

BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study

Biobank For MS And Other Demyelinating Diseases

Emergency Medicine Peer Outreach Worker Engagement for Recovery

Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)

Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)

Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures

A Study Investigating the Efficacy and Safety of LBL-007 Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal Cancer

Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

Trial on Radical Upfront Surgery in Advanced Ovarian Cancer

A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080)

A Study to Evaluate Single Agent Selinexor Versus Physician's Choice in Participants With Previously Treated Myelofibrosis